Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Development of monoclonal antibodies to human kallikrein-related peptidase 6 (KLK6) and their use in an immunofluorometric assay for free KLK6.

Ott C, Ainciburu M, Parent C, Michel S, Roesch C, Vourc'h P, Corcia P, Heuze-Vourc'h N, Jolivet-Reynaud C, Courty Y.

Biol Chem. 2014 Sep;395(9):1119-26. doi: 10.1515/hsz-2014-0133.

PMID:
25153392
2.

Crystal structure of human prostate-specific antigen in a sandwich antibody complex.

Stura EA, Muller BH, Bossus M, Michel S, Jolivet-Reynaud C, Ducancel F.

J Mol Biol. 2011 Dec 9;414(4):530-44. doi: 10.1016/j.jmb.2011.10.007. Epub 2011 Oct 20.

PMID:
22037582
3.

Clostridium perfringens delta toxin is sequence related to beta toxin, NetB, and Staphylococcus pore-forming toxins, but shows functional differences.

Manich M, Knapp O, Gibert M, Maier E, Jolivet-Reynaud C, Geny B, Benz R, Popoff MR.

PLoS One. 2008;3(11):e3764. doi: 10.1371/journal.pone.0003764. Epub 2008 Nov 19.

4.

Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody.

Ménez R, Michel S, Muller BH, Bossus M, Ducancel F, Jolivet-Reynaud C, Stura EA.

J Mol Biol. 2008 Feb 29;376(4):1021-33. doi: 10.1016/j.jmb.2007.11.052. Epub 2007 Nov 22.

PMID:
18187150
5.

Isoelectric point determination of cardiac troponin I forms present in plasma from patients with myocardial infarction.

Peronnet E, Becquart L, Martinez J, Charrier JP, Jolivet-Reynaud C.

Clin Chim Acta. 2007 Feb;377(1-2):243-7. Epub 2006 Oct 13.

PMID:
17113062
6.

SELDI-TOF MS analysis of the Cardiac Troponin I forms present in plasma from patients with myocardial infarction.

Peronnet E, Becquart L, Poirier F, Cubizolles M, Choquet-Kastylevsky G, Jolivet-Reynaud C.

Proteomics. 2006 Dec;6(23):6288-99.

PMID:
17072908
7.

Recombinant kallikrein expression: site-specific integration for hK6 production in human cells.

Heuzé-Vourc'h N, Aïnciburu M, Planque C, Brillard-Bourdet M, Ott C, Jolivet-Reynaud C, Courty Y.

Biol Chem. 2006 Jun;387(6):687-95. Review.

PMID:
16800729
8.

Characterization of prostate-specific antigen binding peptides selected by phage display technology.

Ferrieu-Weisbuch C, Michel S, Collomb-Clerc E, Pothion C, Deléage G, Jolivet-Reynaud C.

J Mol Recognit. 2006 Jan-Feb;19(1):10-20.

PMID:
16312021
9.

Usefulness of the phage display technology for the identification of a hepatitis C virus NS4A epitope recognized early in the course of the disease.

Ferrieu-Weisbuch C, Bettsworth F, Becquart L, Paranhos-Baccala G, Michel S, Arnaud M, Jolivet-Reynaud C.

J Virol Methods. 2006 Feb;131(2):175-83. Epub 2005 Sep 23.

PMID:
16183141
10.

Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients.

Alix-Panabières C, Rebillard X, Brouillet JP, Barbotte E, Iborra F, Segui B, Maudelonde T, Jolivet-Reynaud C, Vendrell JP.

Clin Chem. 2005 Aug;51(8):1538-41. No abstract available.

11.

Comparison of the crystallization and crystal packing of two Fab single-site mutant protein L complexes.

Granata V, Housden NG, Harrison S, Jolivet-Reynaud C, Gore MG, Stura EA.

Acta Crystallogr D Biol Crystallogr. 2005 Jun;61(Pt 6):750-4. Epub 2005 May 26.

PMID:
15930633
12.

Different crystal packing in Fab-protein L semi-disordered peptide complex.

Ménez R, Housden NG, Harrison S, Jolivet-Reynaud C, Gore MG, Stura EA.

Acta Crystallogr D Biol Crystallogr. 2005 Jun;61(Pt 6):744-9. Epub 2005 May 26.

PMID:
15930632
13.

Selective recognition of enzymatically active prostate-specific antigen (PSA) by anti-PSA monoclonal antibodies.

Michel S, Collomb-Clerc E, Geourjon C, Charrier JP, Passagot J, Courty Y, Deléage G, Jolivet-Reynaud C.

J Mol Recognit. 2005 May-Jun;18(3):225-35.

PMID:
15593306
14.

Immunization with hepatitis C virus core gene triggers potent T-cell response, but affects CD4+ T-cells.

Isaguliants MG, Petrakova NV, Kashuba EV, Suzdaltzeva YG, Belikov SV, Mokhonov VV, Prilipov AG, Matskova L, Smirnova IS, Jolivet-Reynaud C, Nordenfelt E.

Vaccine. 2004 Apr 16;22(13-14):1656-65.

PMID:
15068848
15.

Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.

Jolivet-Reynaud C, Adida A, Michel S, Deléage G, Paranhos-Baccala G, Gonin V, Battail-Poirot N, Lacoux X, Rolland D.

J Med Virol. 2004 Mar;72(3):385-95.

PMID:
14748062
16.

Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope.

Petit MA, Jolivet-Reynaud C, Peronnet E, Michal Y, Trépo C.

J Biol Chem. 2003 Nov 7;278(45):44385-92. Epub 2003 Jul 24.

17.

Crystal structure of a hydrophobic immunodominant antigenic site on hepatitis C virus core protein complexed to monoclonal antibody 19D9D6.

Ménez R, Bossus M, Muller BH, Sibaï G, Dalbon P, Ducancel F, Jolivet-Reynaud C, Stura EA.

J Immunol. 2003 Feb 15;170(4):1917-24.

18.

Evidence for plasticity and structural mimicry at the immunoglobulin light chain-protein L interface.

Graille M, Harrison S, Crump MP, Findlow SC, Housden NG, Muller BH, Battail-Poirot N, Sibaï G, Sutton BJ, Taussig MJ, Jolivet-Reynaud C, Gore MG, Stura EA.

J Biol Chem. 2002 Dec 6;277(49):47500-6. Epub 2002 Sep 8.

19.

Involvement of the C-terminal end of the prostrate-specific antigen in a conformational epitope: characterization by proteolytic degradation of monoclonal antibody-bound antigen and mass spectrometry.

Michel S, Forest E, Pétillot Y, Deléage G, Heuzé-Vourc'h N, Courty Y, Lascoux D, Jolivet M, Jolivet-Reynaud C.

J Mol Recognit. 2001 Nov-Dec;14(6):406-13.

PMID:
11757074
20.

An immunoreactive peptide of the FSH involved in autoimmune infertility.

Gobert B, Jolivet-Reynaud C, Dalbon P, Barbarino-Monnier P, Faure GC, Jolivet M, Béné MC.

Biochem Biophys Res Commun. 2001 Dec 14;289(4):819-24.

PMID:
11735119
21.

Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies.

Jolivet-Reynaud C, Lésenéchal M, O'Donnell B, Becquart L, Foussadier A, Forge F, Battail-Poirot N, Lacoux X, Carman W, Jolivet M.

J Med Virol. 2001 Oct;65(2):241-9.

PMID:
11536229
22.

Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation.

Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, Lafon M.

Virology. 2001 Sep 1;287(2):321-32.

23.

Differential diagnosis of prostate cancer and benign prostate hyperplasia using two-dimensional electrophoresis.

Charrier JP, Tournel C, Michel S, Comby S, Jolivet-Reynaud C, Passagot J, Dalbon P, Chautard D, Jolivet M.

Electrophoresis. 2001 May;22(9):1861-6.

PMID:
11425243
24.

Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.

Michel S, Charrier JP, Deleage G, Battail-Poirot N, Jolivet M, Jolivet-Reynaud C.

J Urol. 2001 Jan;165(1):301-6.

PMID:
11125429
25.
26.

Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes.

Jolivet-Reynaud C, Perron H, Ferrante P, Becquart L, Dalbon P, Mandrand B.

Clin Immunol. 1999 Dec;93(3):283-93.

PMID:
10600340
27.

Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling.

Michel S, Deléage G, Charrier JP, Passagot J, Battail-Poirot N, Sibai G, Jolivet M, Jolivet-Reynaud C.

Clin Chem. 1999 May;45(5):638-50.

28.

The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues.

Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessière C, Jolivet-Reynaud C, Jolivet M, Serre G.

J Immunol. 1999 Jan 1;162(1):585-94.

29.

HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection.

Jolivet-Reynaud C, Dalbon P, Viola F, Yvon S, Paranhos-Baccala G, Piga N, Bridon L, Trabaud MA, Battail N, Sibai G, Jolivet M.

J Med Virol. 1998 Dec;56(4):300-9.

PMID:
9829633
30.

Beta2 toxin, a novel toxin produced by Clostridium perfringens.

Gibert M, Jolivet-Reynaud C, Popoff MR.

Gene. 1997 Dec 5;203(1):65-73. Erratum in: Gene 1998 Mar 27;210(1):173. Jolivet-Renaud C [corrected to Jolivet-Reynaud C].

PMID:
9426008
31.

Targeting of GM2-bearing tumor cells with the cytolytic Clostridium perfringens delta toxin.

Jolivet-Reynaud C, Estrada J, West LA, Alout JE, Chedid L.

Anticancer Drugs. 1993 Feb;4(1):65-75.

PMID:
8457717
32.
34.

A new kinetic approach for studying phospholipase C (Clostridium perfringens alpha toxin) activity on phospholipid monolayers.

Moreau H, Pieroni G, Jolivet-Reynaud C, Alouf JE, Verger R.

Biochemistry. 1988 Apr 5;27(7):2319-23.

PMID:
2898259
35.

Damaging effects of Clostridium perfringens delta toxin on blood platelets and their relevance to ganglioside GM2.

Jolivet-Reynaud C, Launay JM, Alouf JE.

Arch Biochem Biophys. 1988 Apr;262(1):59-66.

PMID:
3162668
36.

Purification of alpha toxin from Clostridium perfringens: phospholipase C.

Jolivet-Reynaud C, Moreau H, Alouf JE.

Methods Enzymol. 1988;165:91-4. No abstract available.

PMID:
2906730
37.

Assay methods for alpha toxin from Clostridium perfringens: phospholipase C.

Jolivet-Reynaud C, Moreau H, Alouf JE.

Methods Enzymol. 1988;165:293-7. No abstract available.

PMID:
2906729
38.

Ganglioside identification on human monocyte membrane with Clostridium perfringens delta-toxin.

Cavaillon JM, Jolivet-Reynaud C, Fitting C, David B, Alouf JE.

J Leukoc Biol. 1986 Jul;40(1):65-72.

PMID:
2872258
39.

Photolabeling of staphylococcal alpha-toxin from within rabbit erythrocyte membranes.

Thelestam M, Jolivet-Reynaud C, Alouf JE.

Biochem Biophys Res Commun. 1983 Mar 16;111(2):444-9.

PMID:
6838569
40.

Binding of Clostridium perfringens 125I-labeled delta-toxin to erythrocytes.

Jolivet-Reynaud C, Alouf JE.

J Biol Chem. 1983 Feb 10;258(3):1871-7.

41.

Selective cytotoxicity of Clostridium perfringens delta toxin on rabbit leukocytes.

Jolivet-Reynaud C, Cavaillon JM, Alouf JE.

Infect Immun. 1982 Dec;38(3):860-4.

42.
43.

Purification and characterization of Clostridium perfringens delta-toxin.

Alouf JE, Jolivet-Reynaud C.

Infect Immun. 1981 Feb;31(2):536-46.

Supplemental Content

Loading ...
Support Center